FY24 tissue stainer reagents
Ended Purchase Order Awarded Last action
- Contract number
- W91YTZ23P0111
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $35,170
Award facts
- Opportunity
-
- Tissue Stainer Reagents Solicitation · W91YTZ23Q0185 · Posted Aug 29, 2023
- Contract value 100% obligated
- $35,169.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Gordon, GA 30905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $35,170 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded Agilent Technologies Inc. a $35,169.88 firm fixed price purchase order for tissue stainer reagents on October 1, 2023, with performance completion by September 30, 2024. The contract, issued under solicitation ROF 0011956090, supports pathology and diagnostic operations at Fort Eisenhower, Georgia. As a leading supplier of laboratory consumables and analytical instrumentation, Agilent supplied specialized staining reagents essential to immunohistochemistry applications and tissue analysis performed by military medical facilities. This award reflects a full and open competition with no set-aside designation, demonstrating Agilent's competitive positioning in providing critical laboratory supplies to the Department of Defense health enterprise.
This purchase order represents a tactical procurement action within Agilent's broader strategic engagement with the Defense Health Agency and broader Department of Defense. The company maintains substantial indefinite delivery contracts with military research and medical organizations, including a $14.3 million Indefinite Delivery Contract with the U.S. Army Research, Development and Engineering Command extending through January 2030 for analytical equipment maintenance and repair services. The reagent procurement aligns with Agilent's established role as a preferred vendor for laboratory consumables supporting federal diagnostic, pathology, and research operations across defense medical facilities.
Quick answers
Who was awarded contract W91YTZ23P0111?
W91YTZ23P0111 was awarded to Agilent Technologies Inc. by Medical Command (Department of the Army) on October 1, 2023.
How much is contract W91YTZ23P0111 worth?
The government has obligated $35,170 on W91YTZ23P0111.
Which agency awarded contract W91YTZ23P0111?
Medical Command (Department of the Army) awarded W91YTZ23P0111, with funding from Defense Health Agency (Department of Defense).
Was contract W91YTZ23P0111 competed?
The extent of competition for W91YTZ23P0111 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award